Early plasma circulating tumor DNA (ctDNA) changes to predict response to first-line pembrolizumab plus /- chemotherapy in non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Ricciuti, Biagio
Champagne, Christine
Jones, Greg
Lazarus, Tadd Scott
Adeni, Anika E.
Cheng, Michael L.
Oxnard, Geoffrey R.
Awad, Mark M.
机构：
[1] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Inivata, Cambridge, England
[4] Inivata Inc, Austin, TX USA
[5] Massachusetts Gen Hosp, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3518
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)
    Ricciuti, Biagio
    Jones, Greg
    Severgnini, Mariano
    Alessi, Joao, V
    Recondo, Gonzalo
    Lawrence, Marissa
    Forshew, Tim
    Lydon, Christine
    Nishino, Mizuki
    Cheng, Michael
    Awad, Mark
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (03)
  • [2] Cost-effectiveness of first-line pembrolizumab plus chemotherapy for metastatic squamous non-small cell lung cancer (NSCLC).
    Kim, Ashley
    Devine, Beth
    Roth, Joshua A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] NGR-hTNF plus chemotherapy as first-line therapy of non-small cell lung cancer (NSCLC).
    Gregorc, Vanesa
    Zilembo, Nicoletta
    Grossi, Francesco
    De Pas, Tommaso M.
    Rossoni, Gilda
    Pietrantonio, Filippo
    Rijavec, Erika
    Giovannini, Monica
    Citterio, Giovanni
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Pembrolizumab for the first-line treatment of non-small cell lung cancer
    Ninomiya, Kiichiro
    Hotta, Katsuyuki
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (10) : 1015 - 1021
  • [5] Pembrolizumab in Combination with Chemotherapy as First-Line Treatment of Advanced Non-Small Cell Lung Cancer
    Jahan, N.
    Swarup, S.
    Sultan, A.
    Naing, T.
    Mogollon-Duffo, F.
    Ball, S.
    Tun, A.
    Htut, T.
    Dash, A.
    D'Cunha, N.
    Hardwicke, F.
    Awasthi, S.
    Tijani, L.
    Thein, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S917 - S918
  • [6] Circulating endothelial cells for evaluation of tumor response in non-small cell lung cancer patients receiving first-line chemotherapy
    Najjar, Fadi
    Al-Massarani, Ghassan
    Banat, Israa
    Alammar, Moosheer
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2015, 30 (04): : E374 - E381
  • [7] Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA
    Yaung, Stephanie J.
    Woestmann, Corinna
    Ju, Christine
    Ma, Xiaoju Max
    Gattam, Sandeep
    Zhou, Yiyong
    Xi, Liu
    Pal, Subrata
    Balasubramanyam, Aarthi
    Tikoo, Nalin
    Heussel, Claus Peter
    Thomas, Michael
    Kriegsmann, Mark
    Meister, Michael
    Schneider, Marc A.
    Herth, Felix J.
    Wehnl, Birgit
    Diehn, Maximilian
    Alizadeh, Ash A.
    Palma, John F.
    Muley, Thomas
    CANCERS, 2022, 14 (10)
  • [8] Prognostic Role of Circulating Tumor DNA (ctDNA) and Immune Cell Biomarkers in Non-Small Cell Lung Cancer (NSCLC)
    Chae, Y. K.
    Agte, S.
    Davis, A.
    Pan, A.
    Simon, N.
    Mohindra, N.
    Villaflor, V.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2242 - S2242
  • [9] Advanced non-small-cell lung cancer treated with first-line pembrolizumab plus chemotherapy: tumor response dynamics as a marker for survival
    Nishino, Mizuki
    Wang, Xinan
    Ricciuti, Biagio
    Tseng, Shu-Chi
    Park, Hyesun
    Alessi, Joao V.
    Vaz, Victor R.
    Hatabu, Hiroto
    Lin, Xihong
    Christiani, David C.
    Awad, Mark M.
    EUROPEAN RADIOLOGY, 2023, 33 (10) : 7284 - 7293
  • [10] Advanced non-small-cell lung cancer treated with first-line pembrolizumab plus chemotherapy: tumor response dynamics as a marker for survival
    Mizuki Nishino
    Xinan Wang
    Biagio Ricciuti
    Shu-Chi Tseng
    Hyesun Park
    Joao V. Alessi
    Victor R. Vaz
    Hiroto Hatabu
    Xihong Lin
    David C. Christiani
    Mark M. Awad
    European Radiology, 2023, 33 : 7284 - 7293
12345